Across the country, former Depo-Provera patients are filing lawsuits against the medication’s manufacturer, Pfizer, for failing to disclose the heightened risk of meningioma brain tumors associated with prolonged use of the injection. However, not every woman who receives this birth control injection faces the same likelihood of developing a meningioma. Research has begun to clarify which patterns of use carry the highest risk.
Long-Term and Repeated Use of Depo-Provera Linked to Meningioma
The connection between Depo-Provera and meningioma grows stronger the longer a woman relies on the injection. A large national study examining women who underwent surgery for intracranial meningioma found that prolonged use of injectable medroxyprogesterone acetate, the active ingredient in Depo-Provera, was associated with a higher risk of these tumors.
Researchers reported that the danger was driven by continued use for a year or more, rather than a single dose or short course. Because the shot is given every three months, women who depend on it for several years may build up the kind of sustained hormone exposure that this research has flagged.
Warning Signs of Meningioma That May Lead to Diagnosis
Because meningiomas tend to develop quietly, the first hint of trouble is often a symptom rather than the tumor itself. As the growth presses on the brain or nearby structures, it can interfere with vision, memory, hearing, and balance.
Women who have used Depo-Provera may want to watch for warning signs such as:
- Frequent or intensifying headaches
- Blurred or double vision
- Seizures with no prior history
- Weakness or numbness in the limbs
- Trouble with speech, memory, or concentration
A physician can order imaging to confirm whether a meningioma is responsible for these changes. After this diagnosis, your doctor may order surgery, radiation therapy, and other treatments to remove or shrink the tumor. But even after treatment, some patients continue to live with lasting neurological effects.
Meningioma Patients May Be Eligible for a Depo-Provera Lawsuit
Women diagnosed with a meningioma after using Depo-Provera may have the right to hold the manufacturer accountable. Lawsuits against Pfizer allege that the company failed to warn patients and physicians about the tumor risk tied to its product, despite the available evidence. Eligible patients have used Depo-Provera for an extended period—generally a year or longer—and were later diagnosed with an intracranial meningioma.
Compensation Available in a Depo-Provera Lawsuit
A meningioma diagnosis can upend a woman’s health, finances, and peace of mind all at once. A Depo-Provera lawsuit is meant to address the full scope of this harm, with the value of a claim shaped by the severity of the condition and its lasting effect on daily life. Depending on these factors, a claim may seek recovery for damages such as:
- Past and future medical and surgical expenses
- Costs of ongoing care, monitoring, and rehabilitation
- Lost wages and reduced earning capacity
- Physical pain and emotional suffering
- Lasting disability or diminished quality of life
Concerned About Your Meningioma Risk? Speak with Shapiro Legal Group, PLLC
If you used Depo-Provera and have been diagnosed with a meningioma, Shapiro Legal Group, PLLC can help you seek justice. Our attorneys know how unsettling it is to connect a trusted contraceptive to a brain tumor, and we can help you decide what to do next. Contact us today to discuss your options and plan your journey to justice.